Reducing suicide risk in people with psychosis by targeting emotion regulation
Official title: Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
Run by University of Maryland, Baltimore · NCT05440214 · Data updated 2026-11-12
This study is testing a new therapy aimed at helping people with psychosis manage their emotions better to reduce their risk of suicide.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | University of Maryland, Baltimore Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | December 2, 2022 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | October 9, 2026 |
| Trial ID | NCT05440214 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older diagnosed with a psychosis spectrum disorder and exhibiting heightened suicide risk.
✕Probably not a fit
Patients with intellectual disabilities, traumatic brain injuries, or deafness may not benefit from this study due to exclusion criteria.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to address the high rates of suicide among individuals with psychotic disorders by implementing an intervention focused on emotion dysregulation. The intervention involves Dialectical Behavior Therapy Skills Training, which will be evaluated using advanced statistical methods and Ecological Momentary Assessment. By targeting the emotional factors that contribute to suicidal behavior, the study seeks to provide a more effective approach to suicide prevention in this high-risk population.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce suicide rates among individuals with psychotic disorders.
How similar studies have gone: While there is limited research specifically targeting emotion dysregulation in this population, similar approaches in other mental health contexts have shown promise.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least 18 years old * Psychosis spectrum disorder as assessed by the Mini International Neuropsychiatric Interview (MINI) for Psychotic Disorder Studies * Heightened suicide risk as determined by a score of 8+ on the Suicide Behaviors Questionnaire-Revised (SBQ-R). This cutoff may be revised downwards (toward lower suicide risk) if recruitment appears difficult, but will not be revised upwards. * Enrollment and engagement in outpatient mental health services with at least one mental health service in the previous month * 6+ grade equivalent reading level as assessed by the Wide Range Achievement Test 4 (WRAT-4) Exclusion Criteria: * Chart diagnosis of intellectual disability (DSM5 317, 318), traumatic brain injury, or deafness.
Where it's running
-
University of Maryland
Baltimore, Maryland, United States Recruiting
Study contacts
- Study coordinator: Peter L Phalen, PsyD'
- Email: pphalen@som.umaryland.edu
- Phone: 410-706-2490
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Examining the effects of combined therapy for schizophrenia
This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
State Representation in Early Psychosis 2
This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Combined brain stimulation and yoga for improving cognition in psychosis
This study tests whether active brain stimulation plus yoga can improve thinking skills and daily function in adults with psychosis.
-
See if an early-detection program reduces time to treatment for first-episode psychosis
We test whether a large, region-wide early-detection program can shorten the time from first psychotic symptoms to treatment and help people function better later.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.